Céline Hardy

MD/PhD student, Upstate Medical University | Waickman lab | QU Alum

[Céline Hardy @Clinehardy3]

I don’t usually take a night off from lab and school work but when I do.. it’s to paint the bladder urothelium 🔬🎨 @virchow #gupath #pathart

[Laboratory Investigation @LIjournal]

APRIL PUBLISHED ARTICLE: Slotman et al.

"These findings indicate that nuclear morphometry and automated mitotic figure counts can be used to objectively differentiate between grades of NPUC."
@AvaSlotman @DrReganBaird @Clinehardy3 @virchow #pathology

https://t.co/33vr881rb3

[Céline Hardy @Clinehardy3]

@sherberg128 @ayushi2806 @rajanyag24 @Neurostrat Cheers @HaiyanLi16 and best of luck! It’s been such a pleasure working with the entire group this summer. I am so thankful to have joined such an enthusiastic and welcoming team, especially @Neurostrat who has been such a great mentor and friend!

[David M. Berman @virchow]

"Hardy et al.'s findings are valuable for establishing parsimonious protein-based assays that can eliminate redundancy and enhance ease and practicality in the clinical setting. Thanks, @FaltasLab and@urotday for the shoutout. @IBCN1997 @fabiotavora

[UroToday.com @urotoday]

Using immunohistochemistry for practical molecular subtyping of #BladderCancer. #ExpertCommentary @FaltasLab @WCMEnglanderIPM discusses work from @Clinehardy3 et al. in @JHCnews > https://t.co/qMmavijh7F @histochemnews @AvaSlotman @GottfridSjodahl @virchow

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

NOT ready for prime time

@pcvblack discusses his insights re: molecular classification of #bladdercancer in a rational manner, devoid of hype and/or hyperbole!

#EAU22 @MRoupret @MariaJRibal @djmcconkey @GottfridSjodahl @LDyrskjot

[Céline Hardy @Clinehardy3]

A HUGE thanks to all involved, and a special thank you to the most amazing mentors, @virchow and @ChelsJackson7 for their endless support of this work 🔬🙂

[Céline Hardy @Clinehardy3]

Extremely excited to share our recent work describing the development of quick, inexpensive, and
exquisitely simple algorithms for #bladdercancer molecular subtyping #LundTax @GottfridSjodahl @ChelsJackson7 @HaGhaedi @avaslotman @virchow @JHCnews
https://t.co/M4eqt2YO5g

[Queens Pathology and Molecular Medicine @QueensPathology]

A triumphant poster session for @avaslotman showing how AI can revolutionize bladder cancer grading. #TheUSCAP @TheoKwast @lalpritu @virchow @queenscri

[European Urology @EUplatinum]

Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes

https://t.co/l6dPPAtkb7

@GottfridSjodahl @UroLiedberg

"Urothelial cancer of the luminal-like subtypes is more responsive to cisplatin-based neoadjuvant chemotherapy"

[Céline Hardy @Clinehardy3]

The Berman lab’s latest work, out now! Outstanding work by @ChelsJackson7 and colleagues 🌟it’s been an honour and pleasure being involved in this project

[David M. Berman @virchow]

Hot off the press, a tour-de-force paper led by @ChelsJackson7 explores luminal and basal subtyping in EARLY #bladdercancer. How to subtype with only 3 antibodies; how stable are subtypes? How aggressive? https://t.co/rkNs0kzdUE

[David M. Berman @virchow]

Hot off the press, a tour-de-force paper led by @ChelsJackson7 explores luminal and basal subtyping in EARLY #bladdercancer. How to subtype with only 3 antibodies; how stable are subtypes? How aggressive? https://t.co/rkNs0kzdUE

[Queen's Health Sciences @QueensUHealth]

FHS is pleased to announce that Dr. David M. Berman (@virchow) has been appointed Head, Department @QueensPathology, starting July 1, 2021
➡️ https://t.co/W332jolAyY

[Céline Hardy @Clinehardy3]

Such a huge accomplishment, but its just the tip of the iceberg for this bladder cancer superstar🌟🌟🌟The BIGGEST of congratulations to Dr. Chelsea Jackson: the most outstanding researcher and scientist; not to mention, the best mentor, colleague and friend you could ask for.

[David M. Berman @virchow]

My first breast cancer publication after >30 yrs in the biz. Bottom line: Good Rad-Path correlation or positive surgical margins in lumpectomies -- the choice is ours. https://t.co/FGRMVl4kiQ #olddognewtrick Congrats to Dr. Paola Nasute.

[Céline Hardy @Clinehardy3]

Fresh off the press from the Koti and Berman labs! Thankful to have been a part of the amazing team working on this paper. Huge congrats to Stephen, @ChelsJackson7 and all those involved!

[Céline Hardy @Clinehardy3]

@DavidLillicrap Thank you so much Dr. Lillicrap, you’re too kind! Likewise; it’s been a pleasure.

[Céline Hardy @Clinehardy3]

@_MatthewCormier @tonygismo @virchow @ChelsJackson7 Thank you so much Matt!! 🙂

[Céline Hardy @Clinehardy3]

MSc = ✅ Thank you to my committee, amazing friends and colleagues, and most importantly: @virchow and @ChelsJackson7 for their mentorship and endless support. While I’m so sad to leave behind Queen’s and the Berman lab, I’m so excited for what’s to come! Next up: MD/PhD👩‍⚕️🔬

[Céline Hardy @Clinehardy3]

@CanImmun @virchow @ChelsJackson7 Thanks so much Dr. Koti!

[Céline Hardy @Clinehardy3]

@MulliganLab Thank you!! I'm so thankful for all the opportunities and exceptional training DPMM and the Cancer grad program have provided me with. I'll miss everyone in this outstanding department so much!

[OMPRN @OntarioPath]

📢 @OICR_news announces new OMPRN Director, Dr. Harriet Feilotter from @queensu.

🎉 Please join us in congratulating Dr. Feilotter on her new role as OMPRN Director!

Read the announcement letter here: https://t.co/icCAnacdqq

#cancer #molecular #pathology #leadership